Hyperion Defi (HYPD) Other Non-Current Assets (2018 - 2026)
Hyperion Defi (HYPD) posted quarterly Other Non-Current Assets of $1.9 million for Q1 2026, up 388249.7% year-over-year from N/an in Q1 2025, and up 34.3% quarter-over-quarter from $1.4 million in Q4 2025.
Hyperion Defi (HYPD) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Other Non-Current Assets for 9 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 388249.7% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 388249.7% YoY), while the FY2025 annual figure was $1.4 million, down 6.31% from the prior year.
- Other Non-Current Assets grew to $1.9 million in Q1 2026 per HYPD's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $7.9 million in Q2 2022 and bottomed at $501.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $88246.5 in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 99.66% — and 2026, when it soared 388249.7%.
- Hyperion Defi's Other Non-Current Assets stood at $26745.0 in 2022, then surged by 340.46% to $117800.0 in 2023, then soared by 1212.65% to $1.5 million in 2024, then fell by 6.31% to $1.4 million in 2025, then soared by 34.3% to $1.9 million in 2026.
- Business Quant data shows HYPD's Other Non-Current Assets at $1.9 million in Q1 2026, $1.4 million in Q4 2025, and $238029.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 62.96 Mn |
| 10 | Hyperion Defi | 46.06 Mn | 36.43 Mn | 357,693.00 | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 238,029.00 |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 501.00 |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 18,424.00 |
| Jun 30, 2024 | 58,693.00 |
| Jun 30, 2023 | 117,800.00 |
| Mar 31, 2023 | 54,296.00 |
| Dec 31, 2022 | 26,745.00 |
| Sep 30, 2022 | 32,226.00 |
| Jun 30, 2022 | 7.88 Mn |
| Mar 31, 2022 | 33,579.00 |
| Dec 31, 2021 | 7.88 Mn |
| Sep 30, 2021 | 119,035.00 |
| Jun 30, 2021 | 119,035.00 |
| Mar 31, 2021 | 50,250.00 |
| Dec 31, 2020 | 11,734.00 |